Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 17Recruiting 10Active not recruiting 3Not yet recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Neoplasms 1Lung Neoplasms 1Financial Stress 1Breast Neoplasms 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Mass Screening × Clear all
NCT06430840 2026-01-22

CAN-ASSIST

University of California, Irvine

Phase NA Active not recruiting
91 enrolled

Financial Stress, Neoplasms

NCT06019988 2025-07-25

Breast_SBDOH

Abramson Cancer Center at Penn Medicine

Phase NA Active not recruiting
2,500 enrolled
Breast

Breast Neoplasms

NCT02247453 2024-03-07

BIOMILD

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting
4,119 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡